Wuxi Apptec

© Getty Images

WuXi Biologics bioconjugates spinout plans $470 million IPO

By Liza Laws

The Chinese contract research, development and manufacturing organization (CRDMO) WuXi XDC has launched a bid to raise up to HK$3.7 billion (US$470.3 million) in an initial public offering (IPO) on the Hong Kong Stock Exchange.